Your browser doesn't support javascript.
loading
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Visuri, Isabella; Eriksson, Carl; Karlqvist, Sara; Lykiardopoulos, Byron; Karlén, Per; Grip, Olof; Söderman, Charlotte; Almer, Sven; Hertervig, Erik; Marsal, Jan; Malmgren, Carolina; Delin, Jenny; Strid, Hans; Sjöberg, Mats; Bergemalm, Daniel; Hjortswang, Henrik; Halfvarson, Jonas.
Affiliation
  • Visuri I; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 30, Örebro, SE-70182 Sweden.
  • Eriksson C; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Karlqvist S; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Lykiardopoulos B; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Karlén P; Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden.
  • Grip O; Department of Internal Medicine, Danderyd Hospital, Stockholm, Sweden.
  • Söderman C; Department of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden.
  • Almer S; Department of Internal Medicine, St Göran Hospital, Stockholm, Sweden.
  • Hertervig E; Department of Medicine Solna, Division of Gastroenterolgy, Karolinska Institutet, Stockholm, Sweden.
  • Marsal J; IBD-Unit, Division of Gastroenterology, Karolinska University Hospital, Stockholm, Sweden.
  • Malmgren C; Department of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden.
  • Delin J; Department of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden.
  • Strid H; Takeda Pharma AB, Stockholm, Sweden.
  • Sjöberg M; Department of Gastroenterology, Ersta Hospital, Stockholm, Sweden.
  • Bergemalm D; Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden.
  • Hjortswang H; Department of Internal Medicine, Skaraborgs Hospital, Lidköping, Sweden.
  • Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Therap Adv Gastroenterol ; 16: 17562848231174953, 2023.
Article in En | MEDLINE | ID: mdl-37274297
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Therap Adv Gastroenterol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Therap Adv Gastroenterol Year: 2023 Type: Article